UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
了解自身反应性 T 细胞致病性
基本信息
- 批准号:8835343
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-05 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AutoantigensAutoimmune DiseasesAutoimmunityBehaviorCD28 geneCD4 Positive T LymphocytesCell physiologyCellsEventExperimental Autoimmune EncephalomyelitisGene TargetingGenesGenetic TranscriptionGoalsGranulocyte-Macrophage Colony-Stimulating FactorGreen Fluorescent ProteinsHelper-Inducer T-LymphocyteImmuneImmune responseImmunizationImmunosuppressive AgentsIn VitroInterferonsInterleukin-1Interleukin-10Interleukin-17LaboratoriesMediatingModelingMolecularMultiple SclerosisMusNeuraxisPathogenicityPlayPopulationProcessProductionProteinsReceptor SignalingRegulationRegulator GenesReporterReportingResistanceRoleSignal TransductionSupplementationSystemT-LymphocyteTestingTranscription CoactivatorTranscription Repressor/CorepressorTranscriptional RegulationWorkautoreactive T cellbasecell typecytokineinsightmouse modelneuroinflammationnew therapeutic targetpreventpublic health relevanceresearch studyresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): CD4 T helper (TH) cells drive autoimmunity through their production of proinflammatory cytokines. The molecular determinants controlling the cytokine production and pathogenicity of autoreactive T cells remain unclear. In experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), TH1, TH17 infiltrate the central nervous system (CNS). Remarkably, IFN-� and IL-17, the hallmark cytokines produced by TH1 and TH17 lineages, are not required for encephalitogenicity. Instead, the TH cell- cell-derived cytokine granulocyte-macrophage colony stimulating factor (GM-CSF, encoded by Csf2) plays a nonredundant role in mediating neuroinflammation. Immunosuppressive cytokines produced by autoreactive T cells, including IL-10, also influence T cell encephalitogenicity. We have discovered that mice deficient for the transcription factor Bhlhe40 are resistant to the induction of EAE. Bhlhe40-/- TH cells produce normal amounts of their hallmark cytokines, but produce decreased amounts of GM-CSF and increased amounts of IL-10. We will test the central hypothesis that Bhlhe40 is a required determinant for the pathogenicity of autoreactive T cells. In Aim 1, we will determine the mechanistic basis for Bhlhe40 function in neuroinflammation, testing the hypothesis that the nonencephalitogenicity of Bhlhe40-/- T cells is due to their cell-intrinsic IL-10 production. We will also test the hypothesi that Bhlhe40 acts as a direct transcriptional regulator of genes controlling autoreactive TH cell pathogenicity and determine the structural features of the Bhlhe40 protein required for this transcriptional regulation. In Aim 2, we will use Bhlhe40-green fluorescent protein (GFP) reporter mice to identify the signals that induce Bhlhe40 expression in T cells and test the hypothesis that Bhlhe40 expression determines the pathogenicity of autoreactive T cells. These studies will contribute to our understanding of how T cells acquire autoaggressive effector functions and could identify Bhlhe40 as a novel therapeutic target for the treatment of autoimmune disease.
描述(由申请人证明):CD4 T助手(Th)细胞促进其促炎细胞因子,以控制自动反应性T细胞的细胞因子生产和病原体。 TH1,中枢神经系统(CNS)和Th17谱系,脑作用不需要。自动反应性的细胞因子告诉IL-10 d,缺乏THLHE40的小鼠具有抗EAE的诱导性,但是我们将测试BHLHE40的中心假设,但量减少了GM-CSF。在AIM 1 s中,BHLHE40在神经炎症中的功能中的自动反应性T-细胞的决定因素,测试了BHLHE40 - / - T细胞的非脑质量的假设。假设BHLHE40充当控制自动反应性H细胞病原体的基因的直接转录调节剂,并确定AIM 2中所需的BHLHE40蛋白的结构特征INTIFY THAT INDUHE40 EXPRESSION in T CELLS and TEST THE HYPOTHESIS THAT HLHE40 EXPRESSIS THE PATHOGENICTY OF AUTOREACTIVE T CELLS. THE STUDIES WILL CONTRIBUTE TO OUR UNDERSTANDING OF TELLS AUTOIRE AUTOIRE AUTOIRE GRESSIVE EFFECTOR Functions and Coulde Identify BHLHE40 AS AS AS AS AS AUTOIMMUNE DISEASEASEASEASEASEASEASESEASEASEASEASEASEASESE.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Todd Edelson其他文献
Brian Todd Edelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Todd Edelson', 18)}}的其他基金
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
- 批准号:
10432434 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Role of Intestinal Parasites on Regulating Immune Responses to Gut Antigens
肠道寄生虫在调节肠道抗原免疫反应中的作用
- 批准号:
10445670 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Role of Intestinal Parasites on Regulating Immune Responses to Gut Antigens
肠道寄生虫在调节肠道抗原免疫反应中的作用
- 批准号:
10651714 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
- 批准号:
10612453 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Immunologic Characterization of CSF microglia in multiple sclerosis
多发性硬化症脑脊液小胶质细胞的免疫学特征
- 批准号:
10196298 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Immunologic Characterization of CSF microglia in multiple sclerosis
多发性硬化症脑脊液小胶质细胞的免疫学特征
- 批准号:
10374170 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Regulation of Immune Responses to Mycobacterium tuberculosis Infection
结核分枝杆菌感染免疫反应的调节
- 批准号:
10465067 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Regulation of Immune Responses to Mycobacterium tuberculosis Infection
结核分枝杆菌感染免疫反应的调节
- 批准号:
10231224 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Regulation of Immune Responses to Mycobacterium tuberculosis Infection
结核分枝杆菌感染免疫反应的调节
- 批准号:
9789818 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
了解自身反应性 T 细胞致病性
- 批准号:
9247751 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
- 批准号:32370955
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病相关因子VGLL3调控DNA损伤应答与肿瘤免疫微环境重塑研究
- 批准号:82341006
- 批准年份:2023
- 资助金额:150 万元
- 项目类别:专项基金项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
MALDI质谱分析用于自身免疫性疾病的快速诊断筛查
- 批准号:22274160
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
核苷酸转移酶cGAS乙酰化修饰抑制剂的设计、合成及抗自身免疫性疾病的机制研究
- 批准号:82273767
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
- 批准号:
10679911 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Characterization of T cells in MOG antibody-associated disease
MOG 抗体相关疾病中 T 细胞的表征
- 批准号:
10737097 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
A modular cell therapy platform for controlling immunological tolerance
用于控制免疫耐受的模块化细胞治疗平台
- 批准号:
10725007 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
- 批准号:
10660882 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别: